对狄克洛芬雅克诱导的急性损伤及其对抗剂识别的机制性见解
Fangli Zhao1, Xiaoxia Zhou1, Junyi Chen1
1Department of Pharmacy, Suzhou Wujiang District Hospital of Traditional Chinese Medicine (Suzhou Wujiang District Second People's Hospital), Suzhou, 215000, Jiangsu, China.
概括
狄克洛菲纳克通过核心点,如CTSB,ALB和AKT1,引起损伤. 天然化合物奎尔丁在减轻这种药物诱导的毒性方面表现有前途.
科学领域:
- 药理学和毒理学 药理学和毒理学
- 计算生物学 计算生物学
- 生物化学 生物化学
背景情况:
- 狄克洛菲纳克是一种常见的非类固醇抗炎药物 (NSAID).
- 狄克洛菲纳克的使用与显著的毒性有关,导致急性损伤 (AKI).
- 底层的确切的分子机制二甲诱导的AKI仍然不完全理解.
研究的目的:
- 阐明涉及迪克洛菲纳克诱导的AKI的关键蛋白质和机制.
- 为了识别潜在的治疗对抗剂的迪克洛菲纳克毒性.
- 整合网络毒理学,计算查和实验验证.
主要方法:
- 网络毒理学分析以确定核心目标.
- 计算机辅助的虚拟选 (分子对接,分子动力学) 用于对手的识别.
- 使用HK-2细胞进行体外实验验证.
主要成果:
- 网络毒理学确定了25个核心目标,包括CTSB,ALB和AKT1,在二甲诱导的AKI中.
- 基因本体学和KEGG通路分析强调了线粒体功能障碍和内分泌抵抗.
- 奎尔因成为一种潜在的对抗剂,改善炎症性细胞因子分泌并逆转HK-2细胞中核心蛋白质的表达.
结论:
- 迪克洛菲纳克通过一个复杂的网络诱导AKI,其中包括CTSB,ALB和AKT1.1等目标.
- 奎尔丁显示出作为一种天然抗剂的潜力,可以减轻二二甲引起的毒性.
- 这项研究提供了一种多方面的方法来理解和潜在地治疗药物诱导的损伤.
相关概念视频
01:30Acute Kidney Injury IV: Diagnostic Studies and Prevention
244
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
244
01:29Acute Kidney Injury II: Pathophysiology
856
Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
856
01:20Acute Kidney Injury V: Interprofessional Care
282
Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
282
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
888
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
888
01:22Acute Kidney Injury I: Introduction
530
Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
530
01:11Renal Failure: Dose Adjustments
407
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
407